Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8736525 | Autoimmunity Reviews | 2017 | 21 Pages |
Abstract
To date, available evidence is still limited to support the indication to stop oral anticoagulation therapy in patients with a previous diagnosis of thrombotic APS who subsequently developed a negative aPL profile. The identification of the whole risk profile for cardiovascular manifestations and possibly of a second level aPL testing in selected patients with aPL might support the eventual clinical decision but further investigation is warranted.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
S. Sciascia, E. Coloma-Bazán, M. Radin, M.L. Bertolaccini, C. López-Pedrera, Gerard Espinosa, P.L. Meroni, R. Cervera, M.J. Cuadrado,